Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by captatedon Feb 18, 2010 10:27pm
188 Views
Post# 16798337

RE: RE: I also bet in view of the friendly financi

RE: RE: I also bet in view of the friendly financiThanks for posting that FDA cert doc Francois. Your use of documentation to support your claims and to generally inform is most welcome. But I don't understand why you seem to feel the latest Abraxis money is not connected to the historical tie between new Abraxis money and a new manufacturing facility. At the same time, your seeing as undesirable a client becoming a manufacturing partner would seem to offer an explanation for why you would not want there to be any such connection between latest financing and development of manufacturing partnership with Abraxis. Are you making the evidence fit your wishes?
Bullboard Posts